Recombinant Human IL-2 Protein, Animal-Free BT-002-AFL-050 from R&D Systems, a Bio-Techne Brand

Product Specs
ItemRecombinant Human IL-2 Protein, Animal-Free
CompanyR&D Systems, a Bio-Techne Brand
Price $320.00Supplier Page View Company Product Page
Catalog NumberBT-002-AFL-050
Size50 ug (also 1 mg)
ApplicationsBioactivity
Conjugate/TagUnconjugated
FormatLyophilized from a 0.2 µm filtered solution in Sodium Acetate with Trehalose
Molecular WeightObserved: 13 kDa, under reducing conditions.
Theoretical: 15.5 kDa
SpeciesHuman
Molecule NameIL-2
Source/Expression SystemE. coli-derived Recombinant Human IL-2 Protein, Animal-Free
NCBI Full Gene Nameinterleukin 2
NCBI Gene Aliaseslymphokine, TCGF, IL-2
StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution
Purity>97%, by SDS-PAGE with quantitative densitometry by Coomassie® Blue Staining

Add to Compare List

R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

Company Profile

Website: http://www.rndsystems.com

(1) Increased functional potency of multi-edited CAR-T cells manufactured by a non-viral transfection systemMolecular Therapy - Methods & Clinical DevelopmentMarch 13, 2025Aine O’Sullivan, Sarah Case, Aisling McCrudden, Emer Hackett, Louise Gallagher, Darren Martin, Gillian P. Johnson, Kirti Mahadik, Thomas Kienzle, Jude Kevin Lim, et al.5% Human AB Serum (Bio IVT HUMANABSRMP-1), 120 IU/mL human IL-2 (Cellgenix, 1020-050 or Bio-Techne, BT-002-AFL-050), and activated using TransAct (Miltenyi Biotec 130-111-160) at a final concentration of 10 μL/1 × 106

(2) Dynamic allostery in the peptide/MHC complex enables TCR neoantigen selectivityNat CommunJanuary 20, 2025Jiaqi Ma, Cory M. Ayres, Chad A. Brambley, Smita S. Chandran, Tatiana J. Rosales, W. W. J. Gihan Perera, Bassant Eldaly, William T. Murray, Steven A. Corcelli, Evgenii L. Kovrigin, et al.(STEMCELL Technologies 200-0092) were stimulated with TransAct (Miltenyi Biotech 130-111-160) and rhIL-2 (Biotechne BT-002-AFL-050; 30 IU/mL) for 48 h prior to transduction. Stimulated cells were plated at (1–5) × 105 cells/well and

(3) TET2-mediated tumor cGAS triggers endothelial STING activation to regulate vasculature remodeling and anti-tumor immunity in liver cancerNature communicationsJanuary 4, 2024Lv H, Zong Q, Chen C, Lv G, Xiang W, Xing F, Jiang G, Yan B, Sun X, Ma Y, et al.

Be the First to Write a Review!

Animal-Free™ IL-2 Protein